AI Verdict
IMMX has stronger fundamentals based on our AI analysis.
IMNN vs IMMX Fundamental Comparison
| Metric | IMNN | IMMX |
|---|---|---|
| Revenue | $500,000.0 | $20.0M |
| Net Income | $-14.5M | $-29.4M |
| Net Margin | -2,899.0% | -147.2% |
| ROE | -205.3% | -31.4% |
| ROA | -118.0% | -28.1% |
| Current Ratio | 2.32x | 10.01x |
| Debt/Equity | 0.86x | 0.00x |
| EPS | $-6.83 | $-0.89 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IMNN vs IMMX: Frequently Asked Questions
Is IMNN or IMMX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IMMX has stronger fundamentals. IMNN is rated STRONG SELL (95% confidence) while IMMX is rated SELL (75% confidence). This is not investment advice.
How does IMNN compare to IMMX fundamentally?
Imunon, Inc. has ROE of -205.3% vs Immix Biopharma, Inc.'s -31.4%. Net margins are -2,899.0% vs -147.2% respectively.
Which stock pays higher dividends, IMNN or IMMX?
IMNN has a dividend yield of N/A or no dividend while IMMX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IMNN or IMMX for long term?
For long-term investing, consider that IMNN has STRONG SELL rating with 95% confidence, while IMMX has SELL rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IMNN vs IMMX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMNN vs IMMX, the AI consensus favors IMMX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.